Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 2
2005 1
2006 1
2007 2
2008 1
2009 1
2010 1
2011 1
2012 4
2013 2
2014 3
2016 2
2017 1
2018 3
2019 4
2020 2
2021 4
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C, Parera M, Català-Moll F, Casadellà M, Elizalde-Torrent A, Aguiló M, Espadaler-Mazo J, Santos JR, Paredes R, Noguera-Julian M. Blázquez-Bondia C, et al. Among authors: parera m. Front Immunol. 2022 Dec 8;13:1066036. doi: 10.3389/fimmu.2022.1066036. eCollection 2022. Front Immunol. 2022. PMID: 36569851 Free PMC article. Clinical Trial.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Podzamczer D, et al. Among authors: parera m. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. J Antimicrob Chemother. 2023. PMID: 37725999 Clinical Trial.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Bailón L, Llano A, Cedeño S, Escribà T, Rosás-Umbert M, Parera M, Casadellà M, Lopez M, Pérez F, Oriol-Tordera B, Ruiz-Riol M, Coll J, Perez F, Rivero À, Leselbaum AR, McGowan I, Sengupta D, Wee EG, Hanke T, Paredes R, Alarcón-Soto Y, Clotet B, Noguera-Julian M, Brander C, Molto J, Mothe B; AELIX002 Study Group. Bailón L, et al. Among authors: parera m. Nat Med. 2022 Dec;28(12):2611-2621. doi: 10.1038/s41591-022-02060-2. Epub 2022 Oct 27. Nat Med. 2022. PMID: 36302893 Clinical Trial.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Borgognone A, Noguera-Julian M, Oriol B, Noël-Romas L, Ruiz-Riol M, Guillén Y, Parera M, Casadellà M, Duran C, Puertas MC, Català-Moll F, De Leon M, Knodel S, Birse K, Manzardo C, Miró JM, Clotet B, Martinez-Picado J, Moltó J, Mothe B, Burgener A, Brander C, Paredes R; BCN02 Study Group. Borgognone A, et al. Among authors: parera m. Microbiome. 2022 Apr 11;10(1):59. doi: 10.1186/s40168-022-01247-6. Microbiome. 2022. PMID: 35410461 Free PMC article. Clinical Trial.
Evolution of the gut microbiome following acute HIV-1 infection.
Rocafort M, Noguera-Julian M, Rivera J, Pastor L, Guillén Y, Langhorst J, Parera M, Mandomando I, Carrillo J, Urrea V, Rodríguez C, Casadellà M, Calle ML, Clotet B, Blanco J, Naniche D, Paredes R. Rocafort M, et al. Among authors: parera m. Microbiome. 2019 May 11;7(1):73. doi: 10.1186/s40168-019-0687-5. Microbiome. 2019. PMID: 31078141 Free PMC article.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Borgognone A, Elizalde-Torrent A, Casadellà M, Romero L, Escribà T, Parera M, Català-Moll F, Noguera-Julian M, Brander C, Olvera A, Paredes R. Borgognone A, et al. Among authors: parera m. NPJ Biofilms Microbiomes. 2022 Dec 30;8(1):104. doi: 10.1038/s41522-022-00368-y. NPJ Biofilms Microbiomes. 2022. PMID: 36585401 Free PMC article.
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.
Bordoy AE, Saludes V, Panisello Yagüe D, Clarà G, Soler L, Paris de León A, Casañ C, Blanco-Suárez A, Guerrero-Murillo M, Rodríguez-Ponga B, Noguera-Julian M, Català-Moll F, Pey I, Armengol MP, Casadellà M, Parera M, Pluvinet R, Sumoy L, Clotet B, Giménez M, Martró E, Cardona PJ, Blanco I. Bordoy AE, et al. Among authors: parera m. Sci Rep. 2022 Dec 17;12(1):21818. doi: 10.1038/s41598-022-25719-9. Sci Rep. 2022. PMID: 36528712 Free PMC article.
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
Segalés J, Puig M, Rodon J, Avila-Nieto C, Carrillo J, Cantero G, Terrón MT, Cruz S, Parera M, Noguera-Julián M, Izquierdo-Useros N, Guallar V, Vidal E, Valencia A, Blanco I, Blanco J, Clotet B, Vergara-Alert J. Segalés J, et al. Among authors: parera m. Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793. doi: 10.1073/pnas.2010817117. Epub 2020 Sep 18. Proc Natl Acad Sci U S A. 2020. PMID: 32948692 Free PMC article.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Guillén Y, et al. Among authors: parera m. Mucosal Immunol. 2019 Jan;12(1):232-246. doi: 10.1038/s41385-018-0083-7. Epub 2018 Aug 31. Mucosal Immunol. 2019. PMID: 30171206 Free article.
44 results